Atsena Therapeutics is a clinical-stage gene therapy company focused on developing treatments for inherited retinal diseases such as X-linked retinoschisis and Leber congenital amaurosis type 1.

Heartflow, Inc. develops AI technology to improve the diagnosis and management of coronary artery disease through coronary computed tomography angiography.

Norm Ai develops AI systems that transform regulations and legal obligations into compliance tools to improve the efficiency of legal and compliance programs for large enterprises.

Surf Internet provides fiber-optic internet services, focusing on expanding its network to underserved communities in the Great Lakes Region.

Abcuro, Inc. is a biotechnology company developing therapies for autoimmune diseases and cancer, with a focus on their lead candidate, ulviprubart, a monoclonal antibody for treating inclusion body myositis.

SelectQuote is a distributor of Medicare insurance policies and healthcare services.

Archive provides a platform for brands to create and manage profitable resale programs, supporting circular economy models to reduce retail's environmental impact.

Timberlyne Therapeutics is a biopharmaceutical company developing novel therapies for autoimmune disorders, focusing on advancing a monoclonal antibody targeting CD38.

Cofactr provides supply chain and logistics management platforms with a focus on risk management tools for various industries.

Angitia Biopharmaceuticals is a clinical-stage biotechnology company developing novel treatments for serious musculoskeletal diseases.

DTiQ provides SaaS-based video, analytics, and optimization solutions to enhance operational efficiency and security for multi-location businesses.

Chartbeat is a media software platform that provides analytics and insights to over 1,000 organizations globally, including major media companies.

Kailera Therapeutics is a clinical-stage biopharmaceutical company developing next-generation therapies for obesity and related metabolic conditions.

PayRange provides IoT software and payment solutions for unattended retail.

Serán Bioscience specializes in advanced drug delivery and pharmaceutical manufacturing solutions, including particle engineering and finished dose capabilities.

1440 Foods is a sports and active nutrition company that produces and distributes market-leading brands such as Pure Protein, MET-Rx, and Body Fortress, focusing on innovation and expanding distribution.

EyeBio is a clinical-stage ophthalmology biotechnology company focused on developing therapies for sight-threatening eye diseases and has expanded its Series A funding to $130 million.

Gynesonics develops minimally invasive solutions for symptomatic uterine fibroids, with their flagship product being the Sonata System®.

Nocturne is a NYC-based blockchain technology company that has raised $6 million in seed funding to develop and deploy their protocol, which enables on-chain private accounts and addresses privacy and user experience challenges within the Ethereum ecosystem.

Aiolos Bio is a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions, with a lead drug candidate, AIO-001, that is a potentially best-in-class TSLP antibody dosed every 6 months.

Virgin Voyages is an adult-only cruise line that offers sea vacations with a variety of culinary experiences, fitness facilities, and entertainment options, departing from multiple international ports.

Nimbus Therapeutics is a clinical-stage company that uses computational chemistry and structure-based drug design to develop novel therapies for immunology, cancer, and metabolic diseases.